GlassScriptPhysician profile
Sidra Usman Saeed
NPI 1245689694
$2,760.77
in general payments reported to CMS, 2019-2025
26 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Sleep Medicine (Family Medicine) provider received nationally (typical 2025 total: $557).
See the full distribution for Sleep Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $495 · 2023: $628 · 2024: $1,251 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,265.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $478.75 | 2022-2025 | Airsupra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $362.82 | 2022-2025 | Nucala, Trelegy Ellipta |
| Insmed, INC. | $352.05 | 2023-2025 | Arikayce |
| Harmony Biosciences LLC | $292.58 | 2022-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $155.39 | 2022-2024 | Dupixent |
| Noah Medical Corporation | $139.05 | 2024 | Galaxy |
| Inspire Medical Systems, INC. | $137.98 | 2023-2025 | Inspire |
| Genzyme Corporation | $113.78 | 2024-2025 | |
| Philips North America LLC | $110.08 | 2023-2024 | (Bo0) Hosp Vent Devices, (9480) Implementation |
| Mylan Specialty L.P. | $108.39 | 2022-2023 | Yupelri |
| Grifols USA, LLC | $80.86 | 2023-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $58.74 | 2023-2025 | Cuvitru, Hyqvia |
| Viatris Specialty LLC | $52.05 | 2025 | Yupelri |
| Axsome Therapeutics, INC. | $48.97 | 2023-2025 | Sunosi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.16 | 2023 | Ofev, Stiolto Respimat |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $33.65 | 2023-2024 | Smartvest |
| Alk-Abello, INC | $32.26 | 2022 | |
| Baxter Healthcare | $24.30 | 2023 | Hillrom - Life 2000 Ventilation System |
| Covis Pharma Gmbh | $23.49 | 2022 | |
| Ani Pharmaceuticals, INC. | $22.07 | 2024 | Purified Cortrophin Gel |
| Lilly USA, LLC | $18.75 | 2025 | Zepbound |
| Mallinckrodt Hospital Products INC. | $17.80 | 2025 | Acthar |
| Optinose US, INC. | $15.62 | 2024 | |
| Resmed Corp | $15.31 | 2023 | |
| Azurity Pharmaceuticals, INC. | $13.49 | 2024 | Horizant |
| Fisher & Paykel Healthcare INC | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidra Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.